Fig. 3From: Safety and efficacy of pyronaridine–artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world studyIntegrated safety analysis peak bilirubin versus A peak ALT and B peak AST. Values are from day 3 until day 28 inclusive. ALT alanine aminotransferase, AL artemether–lumefantrine, AST aspartate aminotransferase, PA pyronaridine–artesunate, ULN upper limit of normalBack to article page